Asset Dedication’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-49
Closed -$2.75K – 1281
2026
Q2
$2.75K Buy
+49
New +$2.55K ﹤0.01% 1001

Other funds holding RPRX

Asset Dedication's RPRX Position: Q3 2026 in Review

Asset Dedication sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 49 shares — an estimated $2.75K sold.

Asset Dedication first reported a position in RPRX in Q2 2026 and held it in 1 quarter. The position peaked at $2.75K in Q2 2026. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Asset Dedication reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
  • Asset Dedication sold 49 Royalty Pharma shares in Q3 2026, an estimated $2.75K.
  • Asset Dedication first reported a position in Royalty Pharma in Q2 2026 and held it in 1 quarter.
  • Asset Dedication's Royalty Pharma position peaked at $2.75K in Q2 2026.
  • 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.